Seeking Lab Partners, FB Full Spec MIT to Convert/ & weaker 7 to Remediate & under utilized 7oH Reactors to fill allocations!

If you or anyone you know, is mnfg 7-OH products and wants to contract competitive input materials. We can slide you into the Que. Capable of producing premium 85%+ 7oH. 10’s of Kilos daily output.

We can fire up an additional reactor to supply up to 500kgs of 7oH monthly. But we don’t want to have substantial capital tied up in inventory.

Your LOI/RFQ will get an SCO/MOU back…

We want to contract our surplus at competitive pricing, to folks whom are actively producing finished 7oH products. Credit worthy vendors can eventually align invoice factoring for 30-90 day, same as cash terms.

What volume of 7oH are you using weekly?

What price per active molecule could win your business?

Open to dialog, and analyzing ways we could add value to each others existing business models.

1 Like

sounds fishy

What reads as “Fishy” to you Mitra?

500kg of 7oh is not just done like that. you are talking about 100k of inputs but didnt mention the million dollars of equipment you need to purify these amounts to any grade people actually wanna buy

Isn’t this stuff(7OH) like synthetic heroin?

A charter partner has been converting for years.

He has a dormant reactor, that can be fired up, to convert 15 kgs of MIT in a single reaction.

He offered to either cater to a client with substantial demands, or to sublet the conversions like any toll manufacturing, processing other people’s MIT into 7 at a fee.

Regardless of the particulars, the opportunity remains viable for the right partner, who seeks to take advantage of the opportunity.

Regardless of the cost of equipment, or the input materials, it’s just an option, to leverage their idle reactor, if it adds value to someone’s business.

I’ve seen several vendors with overages of FB MIT. And sometimes diversified portfolios create more opportunities for businesses. If someone is not interested in the conversion, then clearly it’s not a good fit. I’m just looking at networking various needs and opportunities within the Krataloid ecosystems.

Take it or leave it, matters not. They consistently produce 85% 7oH, and I see a compelled benefit to assist in aligning excess input to output opportunities. If it doesn’t add value to your existing operations, then clearly it’s not a good fit.

PseudoMIT is significantly closer to the effects of heroine. 7oH is much more euphoric while Pseudo is more Anelgesic & a longer functional duration.

Heroine is synthesized from Opium, and not naturally occurring. Where 7oH occurs in very trace amounts it is only synthesized at the potencies which we see today, via laboratory conversion. So I guess there is some correlations. But 7oH can also be incredibly beneficial for folks coping with persistent pain. Where there is not enough clinical data to prove the potential medical applications, scientifically the data holds tremendous promise.

IE Pharmacological Action:

7-Hydroxymitragynine (7-OH)

Extremely high µ-opioid receptor (MOR) affinity — higher than mitragynine and even morphine on a molar basis.

Primary active metabolite of mitragynine; the body converts MG to 7-OH in small amounts.

Strong G-protein biased MOR agonist → less respiratory depression in animal models compared to traditional opioids, but still a risk.

PseudoMIT (Pseudo-mitragynine / Pseudoindoxyl derivative)

Formed through oxidation/ rearrangement of mitragynine.

Has dual/multi-receptor activity, including:

MOR agonism

δ-opioid receptor partial activity

κ-opioid receptor modulation

Shows stronger analgesic potency than mitragynine but smoother onset vs 7-OH in animal studies.

Additionally there are less adverse effects with 7OH than there are of aspirin. Heroin has way more adverse effects than aspirin. Outside of niche chemistry, culturally there is no comparisons between heroin and 7OH. There just isn’t. Anyone who says there is, is misinformed and a shill.

1 Like

I’d love to show the Aspirin and Meltatonin data, to the misinformed.

Aspirin (Acetylsalicylic Acid)

Aspirin is one of the most widely used pharmaceuticals in history — but it carries well-defined and well-documented medical risks, even at normal doses.

Known, clinically established dangers

GI bleeding (can be fatal)

Kidney injury

Stroke from hemorrhage

Reye’s syndrome in children

Irreversible platelet inhibition (blood thinning)

Aspirin is extremely well-studied. Its risk profile is known, quantified, and monitored by regulators for decades.

Melatonin

Melatonin is widely perceived as “benign,” but clinically:

Known risks

Endocrine disruption with chronic use

Mood disturbances in some users

Daytime sedation / cognitive impairment

Possible interactions with SSRIs, antihypertensives, and immunosuppressants

Dramatic variability in product purity and strength (some supplements test at 400%+ labeled dose)

Based strictly on publicly documented poison-control data and coroner-verified case reports in the U.S. [This data avoids dosages or anything that could be interpreted as use guidance.]

-–

:white_check_mark: Comparison of Documented Poison-Control & Fatality Cases

Aspirin vs. Melatonin vs. 7-Hydroxymitragynine (7-OH)

(Based solely on presence in poison-control data + documented severe reactions, including deaths.)

-–

1. Aspirin (Acetylsalicylic Acid)

Poison Control Pattern:

Thousands of calls every year in the U.S.

Overdoses are common, both accidental and intentional.

Salicylate toxicity is a well-known medical emergency.

Severe Outcomes Documented:

Metabolic acidosis

GI bleeding / internal hemorrhage

Kidney failure

Respiratory failure

Documented Deaths:

Hundreds of aspirin-related deaths are confirmed annually in medical examiner databases across the U.S.

Aspirin is among the most common NSAIDs associated with fatal overdose.

Conclusion:

Aspirin has far more documented poison-control cases and fatalities than melatonin or 7-OH combined, because it is widely used and toxic at high blood levels.

-–

2. Melatonin

Poison Control Pattern:

Rapid rise in poison-control calls in the past decade (especially pediatric).

Many exposures are accidental (kids ingesting flavored gummies).

Severe Outcomes Documented:

Vomiting, lethargy, altered mental status

Rare: breathing difficulty & cardiovascular instability

Documented Deaths:

A small number of pediatric deaths in the U.S. over the past several years have been formally linked to melatonin exposures in poison-control center reports.

Deaths remain exceedingly rare compared to the number of exposures.

Conclusion:

Melatonin generates many poison-control calls but extremely few fatal outcomes.

-–

3. 7-Hydroxymitragynine (7-OH)

(Note: Pure 7-OH = different risk profile than raw kratom or whole-leaf products.)

Poison Control Pattern:

Most poison-control cases labeled “kratom” do not distinguish between:

raw leaf,

extracts,

multi-alkaloid products, or

products adulterated with opioids/benzodiazepines.

Pure 7-OH-only cases are rare, [THEY CLAIM] because pure 7-OH is not widely distributed.

Severe Outcomes Documented:

Cases involving respiratory depression,

Dependence/withdrawal,

CNS depression,

in emergency-department reports tied to “kratom products,” though typically not isolated to 7-OH alone.

Documented Deaths:

Deaths attributed to kratom products have been recorded, but:

The majority involve multiple substances (opioids, benzos, alcohol).

Very few, if any, are confirmed to be caused by pure 7-OH alone. [INTERESTING]

Coroners frequently list polydrug toxicity rather than kratom-only events.

Conclusion:

There are far fewer confirmed 7-OH-specific poison-control or fatality reports than Aspirin or Melatonin, but this is due to lower exposure numbers, not proof of lower inherent risk. Data on pure 7-OH remains sparse, incomplete, and confounded by mixed-substance products.

-–

:pushpin: FINAL SUMMARY (Safe, Accurate, and Fully Defensible)

Aspirin

Most dangerous in terms of documented poison-control cases and confirmed deaths.

Decades of data show widespread severe toxicity and hundreds of annual fatalities.

Melatonin

Many poison-control calls (especially pediatric).

Very few deaths; outcomes are rarely severe.

7-OH

Very few documented poison-control cases involving pure 7-OH.

Very few confirmed fatal outcomes directly attributed to 7-OH alone.

Low numbers reflect limited exposure and incomplete reporting, not guaranteed safety.